Evidence map›Paper›PMID 34282727›Full record

ArticleeLife2021

Pak1 kinase controls cell shape through ribonucleoprotein granules.

Joseph O Magliozzi, James B Moseley

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joseph O MagliozziDepartment of Biochemistry and Cell Biology, The Geisel School of Medicine at Dartmouth, Hanover, United States.ORCID 0000-0002-4173-2369
James B MoseleyDepartment of Biochemistry and Cell Biology, The Geisel School of Medicine at Dartmouth, Hanover, United States.ORCID 0000-0002-7354-7416

Funding

Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MIERKE, DALE F · 2016 to 2025
$25.9M
Mechanisms that coordinate cell size with mitotic entryR01GM099774 · NIGMS · DARTMOUTH COLLEGE · PI MOSELEY, JAMES B · 2012 to 2023
$3.9M
Regulation of cytokinesis by cell polarity signalingR01GM133856 · NIGMS · DARTMOUTH COLLEGE · PI MOSELEY, JAMES B · 2019 to 2022
$1.5M
NIGMS NIH HHS P20 GM113132NIGMS NIH HHS R01 GM099774NIGMS NIH HHS R01 GM133856
6 · The paper itself

Abstract

Fission yeast cells maintain a rod shape due to conserved signaling pathways that organize the cytoskeleton for polarized growth. We discovered a mechanism linking the conserved protein kinase Pak1 with cell shape through the RNA-binding protein Sts5. Pak1 (also called Shk1 and Orb2) prevents Sts5 association with P bodies by directly phosphorylating its intrinsically disordered region (IDR). Pak1 and the cell polarity kinase Orb6 both phosphorylate the Sts5 IDR but at distinct residues. Mutations preventing phosphorylation in the Sts5 IDR cause increased P body formation and defects in cell shape and polarity. Unexpectedly, when cells encounter glucose starvation, PKA signaling triggers Pak1 recruitment to stress granules with Sts5. Through retargeting experiments, we reveal that Pak1 localizes to stress granules to promote rapid dissolution of Sts5 upon glucose addition. Our work reveals a new role for Pak1 in regulating cell shape through ribonucleoprotein granules during normal and stressed growth conditions.

Indexed as

Cell Cycle ProteinsCell PolarityCell ShapeCytoskeletonp21-Activated KinasesPhosphorylationProtein Serine-Threonine KinasesRibonucleoproteinsSchizosaccharomycesSchizosaccharomyces pombe ProteinsSignal TransductionCell Cycle ProteinsOrb6 protein, S pombep21-Activated KinasesProtein Serine-Threonine KinasesRibonucleoproteinsSchizosaccharomyces pombe Proteinsshk1 protein, S pombeSTS5 protein, S pombecell biologyOrb6Pak1P bodypolaritypombeS. pombeSts5

Identifiers

PMID34282727
PMCPMC8318594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.